Utilizing an FDA-cleared evidence-based approach, the Levo System reportedly offers a patented method to provide personalized sound therapy while sleeping. According to Otoharmonics, a recently released randomized study by the National Center for Rehabilitative Auditory Research led by James Henry, PhD at the VA Portland Health Care System, demonstrated improved clinical outcomes for tinnitus patients using the Levo System.

The MDEA are the medtech industry’s premier design competition committed to recognizing significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility, said the announcement. The awards program celebrates the accomplishments of the medical device manufacturers, their suppliers, and the many people behind the scenes—engineers, scientists, designers, and clinicians—who are responsible for the cutting-edge products that are saving lives, improving patient healthcare, and transforming medtech—one innovation at a time.

“On behalf of the engineers, scientists, clinicians, and business professionals that contributed to the development of the Levo System, we are deeply honored to be recognized by the Medical Design Excellence Awards,” said Brenda Edin, CMO of Otoharmonics. “From the start, the Levo System was developed with personalized, patient-centric design in mind.”

The 2017 MDEA Juror Panel selected 45 exceptional finalists in nine medical technology product categories. Products were judged based on design and engineering innovation, function and user-related innovation, patient benefits, business benefits, and overall benefit to the healthcare system. The MDEA jury is reportedly comprised of a balance of practicing doctors, nurses, and technicians alongside industrial designers, engineers, manufacturers, and human factors experts.

Source: Otoharmonics, MDEA
Image credit: Otoharmonics